Welcome to the BIOMEDigital session viewer. Browse and sort the growing list of sessions by day or track. All sessions are shown in Eastern Time.
As a Co-Founder and Managing Director at MedWorld Advisors, Dave is focused on inorganic (thru M&A business development), strategic alliances, organic growth and EXIT Strategies for the Med Device, Biotech, and OEM Medtech companies. One of his most recent success stories was the pairing of AIRON USA, a small ventilation company located in Florida , with GE Healthcare and Ford during the height of the COVID crisis, where 50,000 ventilators were produced. This deal was sealed in record time in 12 days.
Mr. Sheppard has been a leader in the Medical Device Industry for more than 30 years. His experience includes positions such as GM and VP, as well as high impact sales and marketing leadership roles at Major 500 Corporations (Covidien, Bard, Cooper and Ciba). His achievements also involve work at start-up organizations (including working pre-IPO on a successful IPO company).
He has become an expert in delivering Organic Growth for companies of all sizes in global environments. He has also successfully obtained EBIT growth thru successful M&A activities.
His worldwide results included completing distribution and licensing deals with international businesses, comprising of Major Fortune 500 companies (i.e. GE, Philips, Siemens, etc.) as well as smaller entities. These experiences have led to a global network of contacts with channel partners, large and small. Dave has been involved in “go-to-market” strategies on every major developed continent (Europe, Asia, Africa, Australia, North and South America).
Now, at MedWorld Advisors, Dave works with clients focused on growth, international channel development and getting companies on the market. He collaborates as he leads the strategic development of client organizations and creates tactical execution plans that help exceed organizational objectives for short and long term growth.
For M&A, the goal is to help small and medium companies maximize their VALUE with their EXIT Strategy and/or achieve SUCCESS with their acquisition Strategy.
For Growth companies, the goal is to collaborate and lead the strategic development of client organizations. The aim is to create a strategic plan that delivers tactical actions which lead to exceeding organizational objectives for short and long term growth.
Dave is dedicated to the success of the MedTech, BioTech, Life Science and Healthcare Industries and the Companies involved within it! He sincerely believes that each of our successes contributes to all of our success!